The Federal Trade Commission says Abbott Laboratories (ABT - Get Report) can proceed with its proposed $25 billion acquisition of St. Jude Medical (STJ) . As a result of the green light, Abbott will sell two medical device units to Tokyo-based Terumo for $1.2 billion. The merger of Abbot and St. Jude was cleared by European antitrust regulators back in November, provided that U.S. regulators were on board with the transaction.